Ante Jelaska - Concepedia

Author

Ante Jelaska

Also Known As

A Jelaska, A. Jelaska, Ante Jelaska, Martin Fisher

Publications

935

Citations

H-Index

Concepts

All Affiliations

Ante Jelaska is an author at Boehringer Ingelheim (United States) specializing in health sciences, medicine, and diabetes.

#	Concept	H-Index	Publications	Citations
1	Health Sciences	1	1	38
2	Medicine	1	1	38
3	Diabetes	1	1	38
4	Endocrinology	1	1	38
5	Pharmacology	1	1	38

Ante Jelaska

Publications

896

Citations

H-Index

Page 1

	Year	Citations
Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes Julio Rosenstock, Ante Jelaska, Guillaume Frappin, Diabetes Care	2014	358
Impact of empagliflozin added on to basal insulin in type 2 diabetes inadequately controlled on basal insulin: a 78‐week randomized, double‐blind, placebo‐controlled trial Julio Rosenstock, Ante Jelaska, Cordula Zeller, Diabetes Obesity and Metabolism	2015	252
Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 ( <scp>SGLT2</scp> ) inhibitor, as add‐on to metformin in type 2 diabetes with mild hyperglycaemia Julio Rosenstock, Leo Seman, Ante Jelaska, Diabetes Obesity and Metabolism	2013	208
Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents Juan C. Salazar, Pedro Cahn, Ram Yogev, AIDS	2008	40
Empagliflozin as Add On to Basal Insulin for 78 Weeks Improves Glycemic Control with Weight Loss in Insulin-Treated Type 2 Diabetes (T2DM) Julio Rosenstock, Ante Jelaska, Fei Wang, Canadian Journal of Diabetes ObesityMetabolic SyndromeDiabetes ManagementWeight LossBasal Insulin	2013	38

Page 1